Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SRSF2 pseudogene 1 (SRSF2P1) is a genomic element classified as a pseudogene related to the canonical gene SRSF2, which encodes a serine/arginine-rich splicing factor involved in pre-mRNA splicing and mRNA processing. SRSF2P1 itself is not believed to express a functional protein and is not considered a therapeutic target or directly implicated in known disease processes. The pseudogene is likely a non-coding segment that arose from duplication or retrotransposition of the SRSF2 gene. No specific biological functions, disease roles, or drug interactions are attributed to SRSF2P1. As is typical for pseudogenes, SRSF2P1 is included in genomic annotation but does not serve as a direct molecular target for drugs, diagnostics, or therapeutics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SRSF2 pseudogene 1 (SRSF2P1).